1. 65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine
   Lois M Mulligan, 2018, Endocrine-Related Cancer CrossRef
2. Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity
   Tariq Alqahtani et al, 2021, Cancers CrossRef
3. Berberine as a Potential Anticancer Agent: A Comprehensive Review
   Abdur Rauf et al, 2021, Molecules CrossRef
4. Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023
   Wen Hou et al, 2024, Chemistry & Biodiversity CrossRef
5. Novel targeted therapeutics for MEN2
   Sara Redaelli et al, 2018, Endocrine-Related Cancer CrossRef
6. G-quadruplex DNA: a novel target for drug design
   Fang-Yuan Teng et al, 2021, Cellular and Molecular Life Sciences CrossRef
7. Salinomycin and its derivatives as potent RET transcriptional inhibitors for the treatment of medullary thyroid carcinoma
   Tariq Alqahtani et al, 2019, International Journal of Oncology CrossRef
8. Crosstalk between G-quadruplex and ROS
   Songjiang Wu et al, 2023, Cell Death & Disease CrossRef
9. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting
   Francesca Romano et al, 2023, Expert Opinion on Therapeutic Patents CrossRef
10. Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes
    Tariq Alqahtani et al, 2023, Cancers CrossRef
11. Scaffolds in cytotoxic drugs and novel antitumor molecules interacting with nucleic acids
    Tian-Miao Ou et al, 2023, Privileged Scaffolds in Drug Discovery CrossRef
12. Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction
    Zhi-Yin Sun et al, 2019, Molecules CrossRef